EF
ADMA icon

Empowered Funds’s ADMA Biologics ADMA Stock Holding History

Empowered Funds’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
+25,722
New +$234K ﹤0.01% 1986
2025
Q2 		– Sell
-293,227
Closed -$5.82M – 1749
2025
Q1 		$5.82M Sell
293,227
-37,982
-11% -$657K 0.08% 337
2024
Q4 		$5.68M Buy
+331,209
New +$6.23M 0.08% 343

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Empowered Funds's ADMA Position: Q2 2026 in Review

Empowered Funds opened a new position in ADMA Biologics (ADMA) in Q2 2026: 25,722 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #1986 among its holdings. This is a return to the name: Empowered Funds previously reported a position in ADMA as recently as Q1 2025.

Empowered Funds first reported a position in ADMA in Q4 2024 and has held it in 3 quarters since. The position peaked at $5.82M in Q1 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Empowered Funds held 25,722 shares of ADMA Biologics worth $215K as of Q2 2026.
  • ADMA Biologics was a new Empowered Funds position in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1986 holding.
  • Empowered Funds first reported a position in ADMA Biologics in Q4 2024 and has held it in 3 quarters since.
  • Empowered Funds's ADMA Biologics position peaked at $5.82M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.